Trial Profile
A multicentre, prospective study of perampanel as an adjunctive therapy on daytime somnolence and sleep quality in adult patients with focal onset epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 06 Dec 2016 Results (n=10) presented at the 70th Annual Meeting of the American Epilepsy Society.
- 24 Feb 2016 New trial record